PeptideStack
5.2kquestions
20kanswers
220users

Is TSH a better monitoring choice than magnesium on liraglutide?

Asked 4 Dec 2024Modified 15 months agoViewed 24k times
14

Stated plainly: TSH · magnesium · liraglutide.

I want to know what the trade-off actually is rather than which option is fashionable.

I would rather have a defensible reason than a marginal improvement.

What does each option buy me, and what does it cost me?

bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
kidney-function
kidney-function

eGFR, creatinine, cystatin C and albuminuria: the acute haemodynamic dip that is not injury, the renal outcome data from the FLOW programme, and…

141 questions
lipids
lipids

Lipid response on treatment: triglycerides, LDL-C, non-HDL-C, ApoB and Lp(a), which of them move with weight loss, and why a fasting panel drawn…

139 questions
thyroid
thyroid

Thyroid questions: the rodent C-cell findings behind the labelled warning, human calcitonin data, TSH drift during weight loss, and the…

23 questions
electrolytes
electrolytes

Sodium, potassium and magnesium during reduced intake and GI losses: what the symptoms of a shortfall look like, when a panel is worth drawing,…

72 questions
shareeditfollowflag
DS
askedDr_Hanne_Solberg36k274 Dec 2024

5 Answers

Accepted answer first, then by votes
16

Accepted answer

Worth being precise here: this is answerable, and the answer is mostly about which tests rather than how many.

A twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.

The part that matters: delta checks — comparing against your own previous value — are far more sensitive than comparing against a population interval, which is the argument for keeping a series rather than a snapshot.

Reference intervals are conventionally the central ninety-five per cent of a reference population, which is the direct cause of the one-in-twenty out-of-range rate on a healthy panel.

The caveat is that a panel is not a diagnosis and interpreting one is a clinician's job, particularly when several values move together.

Same laboratory, same time, same fasting state, or the comparison is not a comparison.

shareimprove this answerflag
ID
answered · acceptedimani_dube8.9k1524 Jan 2025
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
12

The relevant statistical point is that a ninety-five per cent reference interval means one analyte in twenty will read out of range in a healthy person by construction.

A sensible core for this population is a full blood count, renal function with electrolytes, liver enzymes with bilirubin, a fasting lipid panel with apolipoprotein B, HbA1c and thyroid-stimulating hormone.

It helps to be literal here: same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.

External quality assurance schemes document between-laboratory differences on common analytes that routinely exceed the size of clinically interesting changes.

Ordering tests you will not act on generates anxiety and incidental findings, both of which have costs.

Decide the action for each result before you order the test.

shareimprove this answerflag
HP
answeredh_pergande71k1582 Jan 2025
8Worth flagging that a mild enzyme elevation with a normal bilirubin is a different object from a rising one. – bufferline42 3 months ago
add a comment
9

Before reacting to any single value, check whether it is outside the interval by an amount larger than the assay's own variation.

Repeat before you react. A single abnormal value has a substantial probability of being within the combined biological and analytical variation of a normal one.

Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.

Baseline first, then a repeat under identical conditions. Everything else is secondary.

shareimprove this answerflag
LQ
answeredlipid_panel_q36k12721 Dec 2024
Adding for future readers: ask for the reference interval printed beside the result, not just the flag. – forty_two_c 2 days ago
8Thank you — separating "out of range" from "abnormal" is the distinction I needed. – tandem_gradient 8 months ago
add a comment
7

The honest position is that most people order too many analytes and too few time points, when the reverse would be more informative.

Timing matters per analyte: cortisol and testosterone are diurnal, triglycerides are postprandial, and creatinine responds to hydration and to recent training. Fixing the conditions removes most of the noise.

Research-use compounds are not approved for human use, and no panel makes that safer.

One out-of-range value on a twenty-analyte panel is expected. Two on a repeat is a finding.

shareimprove this answerflag
LQ
answeredlipid_panel_q36k12713 Jan 2025
6

Standardise the conditions — same time of day, same fasting state, same laboratory — or you are measuring the conditions rather than yourself.

Haemolysis in the sample raises potassium and several enzymes spuriously. If a result is bizarre, ask whether the sample was flagged before building a theory on it.

Keep the full report, not the number. You will need the units and the interval later.

edited 15 Apr 2025 by triple_agonist_q — removed a claim I could not source

shareimprove this answerflag
TQ
answeredtriple_agonist_q57k3818 Mar 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.